Egetis Therapeutics AB Cash Flow Statement

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2020 - 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2020 - 2016
Net Income	-342.5	-343.6	-326.9	-193.8	-104.5	Upgrade
Depreciation & Amortization	-	3.5	3.6	2.7	2.5	Upgrade
Stock-Based Compensation	-	14.7	8	8.8	1.2	Upgrade
Other Operating Activities	49.1	8.9	6	-2.1	-1.1	Upgrade
Change in Accounts Receivable	-8.6	13.4	-22.9	-10.7	3.1	Upgrade
Change in Other Net Operating Assets	35	75.2	53.8	21.6	-31.3	Upgrade
Operating Cash Flow	-267	-227.9	-278.4	-173.5	-130.1	Upgrade
Capital Expenditures	-1.5	-	-	-	-0.2	Upgrade
Cash Acquisitions	-1.3	-1.2	-	-1.7	-5	Upgrade
Investment in Securities	-	-	-	-	-0.8	Upgrade
Investing Cash Flow	-2.8	-1.2	-	-1.7	-6	Upgrade
Long-Term Debt Issued	-	-	108.8	-	-	Upgrade
Long-Term Debt Repaid	-31.9	-10.2	-5.6	-9.1	-8.9	Upgrade
Net Debt Issued (Repaid)	-31.9	-10.2	103.2	-9.1	-8.9	Upgrade
Issuance of Common Stock	183.2	301.5	381.9	177.4	-	Upgrade
Repurchase of Common Stock	-	-1.5	-	-	-	Upgrade
Other Financing Activities	-11.3	-18.9	-26.2	-12.6	-	Upgrade
Financing Cash Flow	140	270.9	458.9	155.7	-8.9	Upgrade
Foreign Exchange Rate Adjustments	-5.4	5.8	-4.8	3.2	1.1	Upgrade
Net Cash Flow	-135.2	47.6	175.7	-16.3	-143.9	Upgrade
Free Cash Flow	-268.5	-227.9	-278.4	-173.5	-130.3	Upgrade
Free Cash Flow Margin	-430.29%	-494.36%	-483.33%	-767.70%	-341.10%	Upgrade
Free Cash Flow Per Share	-0.73	-0.73	-1.07	-0.89	-0.72	Upgrade
Cash Interest Paid	-	8.5	4.1	0.1	-	Upgrade
Cash Income Tax Paid	0.5	0.3	0.1	-	-	Upgrade
Levered Free Cash Flow	-185.69	-105.33	-159.79	-112.39	-90.55	Upgrade
Unlevered Free Cash Flow	-171.5	-94.33	-157.16	-112.33	-90.43	Upgrade
Change in Working Capital	26.4	88.6	30.9	10.9	-28.2	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.